Parkside Financial Bank & Trust’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12
Closed -$667 2711
2025
Q2
$667 Hold
12
﹤0.01% 2404
2025
Q1
$1.26K Buy
+12
New +$1.04K ﹤0.01% 2033
2024
Q4
Sell
-8
Closed -$779 2141
2024
Q3
$779 Hold
8
﹤0.01% 1746
2024
Q2
$1.29K Hold
8
﹤0.01% 1618
2024
Q1
$1.21K Buy
8
+7
+700% +$1.17K ﹤0.01% 1586
2023
Q4
$377 Hold
1
﹤0.01% 1806
2023
Q3
$533 Hold
1
﹤0.01% 1910
2023
Q2
$521 Buy
+1
New +$562 ﹤0.01% 1889
2022
Q1
Sell
-9
Closed -$6K 1818
2021
Q4
$6K Buy
+9
New +$5.48K ﹤0.01% 1206

Other funds holding AGL

Parkside Financial Bank & Trust's AGL Position: Q3 2025 in Review

Parkside Financial Bank & Trust sold out of Agilon Health (AGL) in Q3 2025, closing a stake of 12 shares — an estimated $667 sold.

Parkside Financial Bank & Trust first reported a position in AGL in Q4 2021 and held it in 9 quarters. The position peaked at $6K in Q4 2021. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

  • Parkside Financial Bank & Trust reported no remaining Agilon Health position as of Q3 2025 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 12 Agilon Health shares in Q3 2025, an estimated $667.
  • Parkside Financial Bank & Trust first reported a position in Agilon Health in Q4 2021 and held it in 9 quarters.
  • Parkside Financial Bank & Trust's Agilon Health position peaked at $6K in Q4 2021.
  • 190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q3 2025, filed 30 Oct 2025.